AKTS
Price
$18.87
Change
-$1.02 (-5.13%)
Updated
Jun 5 closing price
Capitalization
1.1B
88 days until earnings call
Intraday BUY SELL Signals
CRDO
Price
$206.89
Change
-$10.61 (-4.88%)
Updated
Jun 5 closing price
Capitalization
38.16B
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKTS vs CRDO

Header iconAKTS vs CRDO Comparison
Open Charts AKTS vs CRDOBanner chart's image
AKTS vs CRDO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AKTS vs. CRDO commentary
Jun 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a Hold and CRDO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2026
Stock price -- (AKTS: $18.88 vs. CRDO: $206.89)
Brand notoriety: AKTS and CRDO are both not notable
AKTS represents the Biotechnology, while CRDO is part of the Semiconductors industry
Current volume relative to the 65-day Moving Average: AKTS: 66% vs. CRDO: 208%
Market capitalization -- AKTS: $1.1B vs. CRDO: $38.16B
AKTS [@Biotechnology] is valued at $1.1B. CRDO’s [@Semiconductors] market capitalization is $38.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.41B to $0. The market cap for tickers in the [@Semiconductors] industry ranges from $5.3T to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B. The average market capitalization across the [@Semiconductors] industry is $197.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTS’s FA Score shows that 0 FA rating(s) are green whileCRDO’s FA Score has 0 green FA rating(s).

  • AKTS’s FA Score: 0 green, 5 red.
  • CRDO’s FA Score: 0 green, 5 red.
According to our system of comparison, AKTS is a better buy in the long-term than CRDO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTS’s TA Score shows that 1 TA indicator(s) are bullish while CRDO’s TA Score has 5 bullish TA indicator(s).

  • AKTS’s TA Score: 1 bullish, 4 bearish.
  • CRDO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRDO is a better buy in the short-term than AKTS.

Price Growth

AKTS (@Biotechnology) experienced а -8.97% price change this week, while CRDO (@Semiconductors) price change was -12.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.86%. For the same industry, the average monthly price growth was -7.98%, and the average quarterly price growth was -1.75%.

The average weekly price growth across all stocks in the @Semiconductors industry was -7.85%. For the same industry, the average monthly price growth was +10.34%, and the average quarterly price growth was +77.02%.

Reported Earning Dates

AKTS is expected to report earnings on Sep 02, 2026.

CRDO is expected to report earnings on Sep 09, 2026.

Industries' Descriptions

@Biotechnology (-7.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Semiconductors (-7.85% weekly)

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDO($38.2B) has a higher market cap than AKTS($1.1B). CRDO has higher annual earnings (EBITDA): 350M vs. AKTS (-76.75M). CRDO has more cash in the bank: 1.3B vs. AKTS (538M). AKTS has less debt than CRDO: AKTS (11.6M) vs CRDO (16.3M). CRDO has higher revenues than AKTS: CRDO (1.07B) vs AKTS (8.28M).
AKTSCRDOAKTS / CRDO
Capitalization1.1B38.2B3%
EBITDA-76.75M350M-22%
Gain YTDN/A43.783-
P/E RatioN/A113.68-
Revenue8.28M1.07B1%
Total Cash538M1.3B41%
Total Debt11.6M16.3M71%
FUNDAMENTALS RATINGS
AKTS: Fundamental Ratings
AKTS
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKTSCRDO
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AKTS
Daily Signal:
Gain/Loss:
CRDO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDX151.161.60
+1.07%
Becton Dickinson and Co
SFBS78.150.15
+0.19%
ServisFirst Bancshares
FSBC42.93-0.21
-0.49%
Five Star Bancorp
XYF4.71-0.22
-4.46%
X Financial
SINT2.03-0.21
-9.38%
SiNtx Technologies Inc.

AKTS and

Correlation & Price change

A.I.dvisor tells us that AKTS and SPRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTS and SPRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTS
1D Price
Change %
AKTS100%
-5.08%
SPRY - AKTS
29%
Poorly correlated
-5.68%
CRDO - AKTS
24%
Poorly correlated
-4.88%
KN - AKTS
24%
Poorly correlated
-5.34%
LITE - AKTS
24%
Poorly correlated
-8.62%
ZBRA - AKTS
23%
Poorly correlated
-5.45%
More

CRDO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDO has been loosely correlated with ALAB. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDO jumps, then ALAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDO
1D Price
Change %
CRDO100%
-4.88%
ALAB - CRDO
59%
Loosely correlated
-11.45%
AVGO - CRDO
57%
Loosely correlated
-7.92%
CAMT - CRDO
56%
Loosely correlated
-9.40%
AMBA - CRDO
56%
Loosely correlated
-11.84%
KLAC - CRDO
55%
Loosely correlated
-9.47%
More